http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3102944-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e253a451f84201602a4004bca79340bf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f162e90ccf2fa46bae53429c17a8a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f19598c431a26294ccbf5b7f8749563
publicationDate 2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3102944-A1
titleOfInvention Diagnosis of cancer by detecting auto-antibodies against egf-receptor
abstract The present invention relates to a method for diagnosis of a cancer, comprising the steps of (i) determining the level of antibodies against epidermal growth factor receptor (EGFR) in a sample from a subject to be diagnosed, (ii) comparing the determined level in the sample to a control level derived from subjects without cancer; wherein a decreased level in the sample from the subject to be diagnosed as compared to the control level is indicative for cancer in the subject. Furthermore, the invention relates to method of predicting response and outcome of a treatment of a cancer with an inhibitor of EGFR activity.
priorityDate 2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908

Total number of triples: 49.